Loading clinical trials...

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01720212

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

To evaluate the safety and plasma concentration change of YM178 after single- and repeated-administration as oral absorption controlled tablet in healthy Chinese subjects.

Lead sponsor: Astellas Pharma China, Inc.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Study of SYH2062 Injection in Healthy Chinese Volunteers

NCT06842537 · Healthy Chinese Volunteers

COMPLETEDPhase 1

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

NCT03971916 · Healthy Chinese Volunteers

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment24

Start dateMay 2012

Last updatedNov 2, 2012

Condition

Healthy Chinese Volunteers

Locations shown

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2012Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions